 Andrew Bradford
Concepts (339)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 7 | 2021 | 142 | 2.160 |
Why?
| | Follicle Stimulating Hormone | 12 | 2022 | 222 | 1.780 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 191 | 1.770 |
Why?
| | Prolactin | 10 | 2022 | 110 | 1.270 |
Why?
| | Leiomyoma | 3 | 2019 | 39 | 1.210 |
Why?
| | Hyperlipidemias | 3 | 2022 | 143 | 1.200 |
Why?
| | Hyperinsulinism | 3 | 2022 | 111 | 1.190 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 67 | 1.170 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 44 | 1.070 |
Why?
| | Obesity | 12 | 2022 | 2737 | 0.990 |
Why?
| | Pituitary Gland | 7 | 2021 | 174 | 0.970 |
Why?
| | Human Growth Hormone | 1 | 2022 | 49 | 0.900 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 397 | 0.890 |
Why?
| | E2F1 Transcription Factor | 6 | 2023 | 51 | 0.890 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1590 | 0.860 |
Why?
| | Soybean Oil | 1 | 2021 | 15 | 0.860 |
Why?
| | Corpus Luteum | 3 | 2016 | 28 | 0.860 |
Why?
| | Promoter Regions, Genetic | 15 | 2023 | 1247 | 0.830 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 81 | 0.820 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 726 | 0.810 |
Why?
| | Phospholipids | 2 | 2021 | 215 | 0.780 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 23 | 0.760 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1216 | 0.730 |
Why?
| | Insulin | 5 | 2022 | 2209 | 0.650 |
Why?
| | Cell Proliferation | 7 | 2015 | 2382 | 0.620 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 182 | 0.610 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 9 | 0.580 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.570 |
Why?
| | Weight Gain | 2 | 2016 | 507 | 0.550 |
Why?
| | Signal Transduction | 11 | 2021 | 4919 | 0.550 |
Why?
| | Apoptosis | 10 | 2023 | 2639 | 0.550 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 53 | 0.540 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 96 | 0.510 |
Why?
| | Adenocarcinoma | 3 | 2009 | 832 | 0.490 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 320 | 0.470 |
Why?
| | Dietary Fats | 1 | 2015 | 365 | 0.460 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1080 | 0.460 |
Why?
| | Gene Expression Regulation | 10 | 2016 | 2576 | 0.460 |
Why?
| | Transcription Factors | 8 | 2018 | 1661 | 0.450 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1432 | 0.440 |
Why?
| | Cross-Over Studies | 3 | 2022 | 512 | 0.430 |
Why?
| | MicroRNAs | 2 | 2015 | 631 | 0.430 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 54 | 0.430 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.410 |
Why?
| | Protein Kinase C | 2 | 2003 | 349 | 0.400 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 504 | 0.390 |
Why?
| | E2F Transcription Factors | 3 | 2023 | 57 | 0.360 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 172 | 0.360 |
Why?
| | Cell Line, Tumor | 10 | 2021 | 2933 | 0.360 |
Why?
| | Estradiol | 4 | 2015 | 483 | 0.340 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 386 | 0.330 |
Why?
| | Hydrocortisone | 2 | 2022 | 335 | 0.330 |
Why?
| | Female | 30 | 2022 | 64422 | 0.330 |
Why?
| | RNA, Messenger | 2 | 2015 | 2876 | 0.330 |
Why?
| | Menstrual Cycle | 2 | 2019 | 116 | 0.320 |
Why?
| | Growth Hormone | 3 | 2022 | 115 | 0.300 |
Why?
| | Isoenzymes | 3 | 2003 | 354 | 0.280 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 1008 | 0.250 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 122 | 0.240 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 60 | 0.240 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 209 | 0.240 |
Why?
| | Humans | 34 | 2022 | 119016 | 0.240 |
Why?
| | Pituitary Hormones | 1 | 2022 | 19 | 0.230 |
Why?
| | Genes, Tumor Suppressor | 3 | 2023 | 89 | 0.230 |
Why?
| | Cell Cycle Proteins | 3 | 2019 | 573 | 0.230 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 23 | 0.230 |
Why?
| | Thyrotropin | 1 | 2022 | 110 | 0.220 |
Why?
| | Thyroid Hormones | 1 | 2022 | 64 | 0.220 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 396 | 0.220 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 238 | 0.220 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1472 | 0.220 |
Why?
| | Animals | 19 | 2016 | 35392 | 0.220 |
Why?
| | Hypothalamus | 2 | 2014 | 197 | 0.220 |
Why?
| | Rats | 10 | 2006 | 6278 | 0.210 |
Why?
| | Emulsions | 1 | 2021 | 55 | 0.210 |
Why?
| | Heparin | 1 | 2022 | 227 | 0.200 |
Why?
| | Leptin | 1 | 2022 | 239 | 0.200 |
Why?
| | Thinness | 1 | 2021 | 96 | 0.200 |
Why?
| | Adiponectin | 1 | 2022 | 210 | 0.200 |
Why?
| | Phosphorylation | 4 | 2009 | 1754 | 0.200 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 11 | 0.200 |
Why?
| | Creatinine | 1 | 2022 | 472 | 0.200 |
Why?
| | Lipids | 2 | 2022 | 637 | 0.200 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 23 | 0.200 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 293 | 0.200 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 193 | 0.200 |
Why?
| | Wnt Proteins | 1 | 2021 | 148 | 0.200 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 41 | 0.200 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 173 | 0.200 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 18 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 138 | 0.190 |
Why?
| | Cell Cycle | 2 | 2015 | 594 | 0.190 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 66 | 0.190 |
Why?
| | Enzyme Activation | 3 | 2009 | 961 | 0.190 |
Why?
| | beta Catenin | 1 | 2021 | 229 | 0.190 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 34 | 0.180 |
Why?
| | Gonadotropins | 2 | 2015 | 33 | 0.180 |
Why?
| | Transcription Factor DP1 | 1 | 2018 | 19 | 0.180 |
Why?
| | Follicular Phase | 2 | 2015 | 44 | 0.180 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 75 | 0.180 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 160 | 0.180 |
Why?
| | Estrogens | 3 | 2019 | 312 | 0.170 |
Why?
| | Estrone | 2 | 2015 | 31 | 0.170 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 323 | 0.170 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 46 | 0.170 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 223 | 0.170 |
Why?
| | Etoposide | 2 | 2009 | 161 | 0.170 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 198 | 0.170 |
Why?
| | Genes, p16 | 1 | 2016 | 20 | 0.160 |
Why?
| | Fibroblasts | 3 | 2018 | 886 | 0.160 |
Why?
| | Aromatase | 2 | 2014 | 26 | 0.160 |
Why?
| | Oncogene Proteins | 1 | 1996 | 63 | 0.150 |
Why?
| | Genes, ras | 2 | 1997 | 99 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 367 | 0.150 |
Why?
| | Ovulation | 1 | 2015 | 38 | 0.140 |
Why?
| | Dietary Supplements | 2 | 2019 | 467 | 0.140 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 65 | 0.140 |
Why?
| | Cumulus Cells | 1 | 2015 | 9 | 0.140 |
Why?
| | Blotting, Western | 2 | 2009 | 1296 | 0.140 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1433 | 0.140 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.140 |
Why?
| | Adult | 12 | 2021 | 32799 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 366 | 0.130 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 136 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 215 | 0.130 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 104 | 0.130 |
Why?
| | Hormone Antagonists | 1 | 2014 | 49 | 0.130 |
Why?
| | Luteal Phase | 1 | 2014 | 46 | 0.130 |
Why?
| | Cytokines | 3 | 2021 | 1990 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2018 | 475 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1942 | 0.130 |
Why?
| | Transfection | 3 | 2009 | 964 | 0.130 |
Why?
| | Repressor Proteins | 1 | 1997 | 406 | 0.120 |
Why?
| | Circadian Rhythm | 1 | 2017 | 463 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2015 | 271 | 0.120 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 175 | 0.120 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 51 | 0.120 |
Why?
| | Postmenopause | 1 | 2015 | 348 | 0.120 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 25 | 0.120 |
Why?
| | RNA Interference | 2 | 2018 | 500 | 0.120 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2006 | 0.120 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 605 | 0.110 |
Why?
| | Pregnancy | 2 | 2022 | 5546 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 286 | 0.110 |
Why?
| | DNA, Complementary | 2 | 2012 | 286 | 0.110 |
Why?
| | Base Sequence | 3 | 2012 | 2280 | 0.110 |
Why?
| | Testosterone | 1 | 2015 | 341 | 0.110 |
Why?
| | Cell Line | 5 | 2018 | 2937 | 0.110 |
Why?
| | Neoplasms | 2 | 2023 | 2163 | 0.110 |
Why?
| | Pulsatile Flow | 1 | 2011 | 58 | 0.110 |
Why?
| | Protein Isoforms | 2 | 2003 | 361 | 0.110 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 161 | 0.100 |
Why?
| | Cell Survival | 2 | 2021 | 1137 | 0.100 |
Why?
| | Weight Loss | 1 | 2016 | 736 | 0.100 |
Why?
| | Mutation | 1 | 2021 | 3468 | 0.100 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 61 | 0.100 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 102 | 0.100 |
Why?
| | Adiposity | 1 | 2015 | 508 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 74 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1089 | 0.090 |
Why?
| | Luciferases | 1 | 2009 | 153 | 0.090 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 88 | 0.090 |
Why?
| | Cyclin D1 | 1 | 2009 | 69 | 0.090 |
Why?
| | Progesterone | 3 | 2016 | 265 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 473 | 0.090 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 136 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2009 | 104 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 780 | 0.090 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 5 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 433 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 141 | 0.090 |
Why?
| | Models, Biological | 2 | 2016 | 1814 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2015 | 1110 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 335 | 0.090 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 89 | 0.090 |
Why?
| | Myometrium | 1 | 2008 | 36 | 0.090 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 328 | 0.090 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 161 | 0.090 |
Why?
| | Young Adult | 7 | 2020 | 11181 | 0.080 |
Why?
| | Rabbits | 1 | 2009 | 798 | 0.080 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 457 | 0.080 |
Why?
| | Mice, Nude | 1 | 2009 | 704 | 0.080 |
Why?
| | Cell Adhesion | 1 | 2009 | 469 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 131 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 464 | 0.080 |
Why?
| | DNA Primers | 1 | 2008 | 578 | 0.080 |
Why?
| | Subcellular Fractions | 1 | 2006 | 88 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 48 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 72 | 0.080 |
Why?
| | DNA Damage | 1 | 2009 | 373 | 0.080 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 94 | 0.080 |
Why?
| | HeLa Cells | 2 | 2000 | 638 | 0.080 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 79 | 0.080 |
Why?
| | raf Kinases | 1 | 2006 | 12 | 0.080 |
Why?
| | Immunoprecipitation | 1 | 2006 | 176 | 0.080 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 31 | 0.080 |
Why?
| | Autocrine Communication | 1 | 2006 | 45 | 0.080 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 57 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 180 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 420 | 0.070 |
Why?
| | Paracrine Communication | 1 | 2006 | 61 | 0.070 |
Why?
| | Prostate | 1 | 2007 | 177 | 0.070 |
Why?
| | Adolescent | 7 | 2021 | 19192 | 0.070 |
Why?
| | Caspases | 1 | 2006 | 292 | 0.070 |
Why?
| | ras Proteins | 1 | 2006 | 149 | 0.070 |
Why?
| | Mice | 4 | 2012 | 15850 | 0.070 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 193 | 0.070 |
Why?
| | Reproduction | 1 | 2007 | 204 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 889 | 0.070 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.070 |
Why?
| | Body Mass Index | 3 | 2021 | 2099 | 0.070 |
Why?
| | Ovulation Induction | 2 | 2015 | 46 | 0.070 |
Why?
| | Biomarkers | 1 | 2015 | 3583 | 0.070 |
Why?
| | Hypogonadism | 2 | 2015 | 74 | 0.070 |
Why?
| | Cell Movement | 1 | 2009 | 936 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 48 | 0.070 |
Why?
| | Cell Nucleus | 1 | 2007 | 614 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 371 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 249 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 276 | 0.060 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 7 | 0.060 |
Why?
| | Thiocarbamates | 1 | 2003 | 8 | 0.060 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 16 | 0.060 |
Why?
| | Norbornanes | 1 | 2003 | 12 | 0.060 |
Why?
| | Thiones | 1 | 2003 | 16 | 0.060 |
Why?
| | Chromones | 1 | 2003 | 48 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2549 | 0.060 |
Why?
| | Middle Aged | 2 | 2019 | 29243 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 1550 | 0.060 |
Why?
| | Androstadienes | 1 | 2003 | 105 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1802 | 0.060 |
Why?
| | Morpholines | 1 | 2003 | 113 | 0.060 |
Why?
| | Cluster Analysis | 2 | 2015 | 472 | 0.060 |
Why?
| | Acetophenones | 1 | 2001 | 16 | 0.060 |
Why?
| | Benzopyrans | 1 | 2001 | 28 | 0.060 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 3018 | 0.050 |
Why?
| | Models, Molecular | 1 | 2007 | 1550 | 0.050 |
Why?
| | Naphthalenes | 1 | 2001 | 59 | 0.050 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 30 | 0.050 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 28 | 0.050 |
Why?
| | Carbazoles | 1 | 2001 | 95 | 0.050 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 35 | 0.050 |
Why?
| | Indazoles | 1 | 2021 | 71 | 0.050 |
Why?
| | Immunoblotting | 1 | 2001 | 351 | 0.050 |
Why?
| | Adenoviridae | 1 | 2001 | 191 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 389 | 0.050 |
Why?
| | Genetic Fitness | 1 | 2021 | 50 | 0.050 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 96 | 0.050 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 206 | 0.050 |
Why?
| | Aged | 1 | 2019 | 20607 | 0.050 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 145 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 737 | 0.050 |
Why?
| | Imidazoles | 1 | 2021 | 264 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2021 | 350 | 0.050 |
Why?
| | Indoles | 1 | 2001 | 348 | 0.050 |
Why?
| | DNA | 2 | 1997 | 1383 | 0.050 |
Why?
| | Prospective Studies | 3 | 2015 | 6565 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 16 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 81 | 0.040 |
Why?
| | Recurrence | 1 | 2021 | 1013 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 446 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1831 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 382 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 203 | 0.040 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.040 |
Why?
| | Pyridines | 1 | 2021 | 501 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 941 | 0.040 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 17 | 0.040 |
Why?
| | Catalysis | 1 | 1997 | 307 | 0.040 |
Why?
| | Retinoblastoma Protein | 1 | 2016 | 54 | 0.040 |
Why?
| | Disease Management | 1 | 2021 | 609 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 1996 | 135 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 196 | 0.040 |
Why?
| | Infertility, Female | 1 | 2016 | 93 | 0.040 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 127 | 0.040 |
Why?
| | Hormones | 1 | 2016 | 140 | 0.040 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 13 | 0.040 |
Why?
| | Limit of Detection | 1 | 2015 | 53 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 256 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 192 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 79 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1303 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 204 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 426 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 517 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 701 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 352 | 0.030 |
Why?
| | Anions | 1 | 2013 | 37 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 456 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 153 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 347 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 418 | 0.030 |
Why?
| | Genetic Therapy | 1 | 2014 | 268 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 441 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 167 | 0.030 |
Why?
| | Heterografts | 1 | 2012 | 131 | 0.030 |
Why?
| | Gene Library | 1 | 2012 | 111 | 0.030 |
Why?
| | Protein Binding | 1 | 1997 | 2067 | 0.030 |
Why?
| | Male | 4 | 2017 | 61786 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 167 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1272 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 336 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 141 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 897 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 741 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 813 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 4607 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 6 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 13 | 0.020 |
Why?
| | Transcriptome | 1 | 2012 | 730 | 0.020 |
Why?
| | Prognosis | 1 | 2012 | 3592 | 0.020 |
Why?
| | Liver | 1 | 1992 | 1873 | 0.020 |
Why?
| | Suppression, Genetic | 1 | 2003 | 27 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2003 | 98 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2004 | 319 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3894 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2003 | 379 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2163 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 7 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 392 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 355 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 557 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 195 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 429 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 613 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 55 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 154 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 359 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 494 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 361 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 253 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 401 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 888 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 275 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4312 | 0.010 |
Why?
| | Kinetics | 1 | 1992 | 1766 | 0.010 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|